Skip to main content
ProBiotix Health Plc logo

ProBiotix Health Plc — Investor Relations & Filings

Ticker · PBX ISIN · GB00BLNBFR86 LEI · 98450048683CF0388C30 Aquis Stock Exchange Manufacturing
Filings indexed 66 across all filing types
Latest filing 2024-11-01 Declaration of Voting R…
Country GB United Kingdom
Listing Aquis Stock Exchange PBX

About ProBiotix Health Plc

https://www.probiotixhealth.com/

ProBiotix Health Plc is a life sciences company that develops and supplies scientifically validated, probiotic-based microbiome solutions. The company specializes in formulations for cardiometabolic health, targeting conditions related to cholesterol, blood pressure, and vascular health, as well as healthy aging. Its core technology is LPLDL®, a patented and trademarked Lactobacillus plantarum strain demonstrated in human clinical trials to be effective in managing key cardiometabolic markers. ProBiotix Health offers its technology as both a raw ingredient and in finished product formulations, such as the YourBiotix and CholBiome® lines, for the global dietary supplement market. The company's approach is rooted in extensive research and development, conducted in collaboration with universities and scientific advisors to ensure product efficacy and safety.

Recent filings

Filing Released Lang Actions
Result of Requisitioned General Meeting
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is an official announcement from ProBiotix Health plc regarding the outcome of a 'Requisitioned General Meeting'. It explicitly lists the resolutions voted upon, the number of votes cast for and against each, and the final result (resolutions defeated). This falls directly under the definition of a Declaration of Voting Results.
2024-11-01 English
Publication of Circular and Notice of GM
Regulatory Filings Classification · 98% confidence The document is a circular published by ProBiotix Health plc regarding a requisitioned general meeting. It contains the notice of the meeting, the board's recommendation to shareholders to vote against the proposed resolutions, and detailed background information regarding the requisition. This document serves as the primary material sent to shareholders to inform their vote, which fits the definition of a Proxy Solicitation & Information Statement.
2024-10-15 English
New Commercial Partnership in Mexico
Regulatory Filings Classification · 100% confidence The document is a press release distributed via the London Stock Exchange's RNS (Regulatory News Service) announcing a new commercial partnership between ProBiotix Health plc and a Mexican distributor. It does not fit into specific categories like financial reports, dividends, or M&A, and is a standard corporate announcement regarding business operations. Therefore, it falls under the RNS (Regulatory Filings) category.
2024-10-10 English
Q3 2024 Trading Update
Earnings Release Classification · 95% confidence The document is a 'Q3 2024 Trading Update' issued by ProBiotix Health plc via the RNS (Regulatory News Service). It provides key financial highlights (sales, gross profit) and operational updates for the nine-month period ending September 30, 2024. While it contains financial data, it is an initial announcement of results rather than a full interim report or a 10-K. According to the filing definitions, an initial announcement of quarterly/periodical financial results is classified as an Earnings Release (ER). 9M 2024
2024-10-08 English
Appointment of Non-Executive Director
Board/Management Information Classification · 100% confidence The document is an official announcement regarding the appointment of a new Non-Executive Director (Frederik Bruhn-Petersen) to the board of ProBiotix Health PLC. It details his background, shareholding, and current directorships. This falls squarely under the definition of Board/Management Information (MANG).
2024-10-07 English
New Commercial Partnership in Ukraine
Regulatory Filings Classification · 100% confidence The document is a press release distributed via the Regulatory News Service (RNS) regarding a new commercial partnership between ProBiotix Health PLC and a Ukrainian distributor. It does not fit into specific categories like financial reports, board changes, or dividend announcements. As it is a general corporate announcement regarding business operations, it falls under the 'Regulatory Filings' (RNS) category.
2024-10-03 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.